Latest Insider Transactions at Reata Pharmaceuticals Inc (RETA)
This section provides a real-time view of insider transactions for Reata Pharmaceuticals Inc (RETA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REATA PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REATA PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+9.76%
|
-
|
|
Feb 28
2023
|
Colin John Meyer Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+14.22%
|
-
|
|
Jan 03
2023
|
James Warren Huff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,025
+50.0%
|
-
|
|
Jan 03
2023
|
Michael D Wortley Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,675
+23.62%
|
-
|
|
Jan 03
2023
|
Manmeet Singh Soni COO, CFO and President |
BUY
Grant, award, or other acquisition
|
Direct |
23,513
+20.27%
|
-
|
|
Jan 03
2023
|
Colin John Meyer Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,513
+23.74%
|
-
|
|
Jan 03
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
11,756
+20.86%
|
-
|
|
Jan 03
2023
|
Samina Khan SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,756
+20.04%
|
-
|
|
Jan 03
2023
|
Dawn Carter Bir Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,675
+23.62%
|
-
|
|
Jan 03
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,250
+25.0%
|
-
|
|
Jul 11
2022
|
Steven Ryder Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,878
+41.67%
|
$284,096
$32.36 P/Share
|
|
Jun 08
2022
|
Martin Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,242
+46.82%
|
$144,228
$34.76 P/Share
|
|
Jun 08
2022
|
William D. Mc Clellan Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,170
+46.6%
|
$141,780
$34.76 P/Share
|
|
Jun 08
2022
|
Christy J. Oliger Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,883
+50.0%
|
$132,022
$34.76 P/Share
|
|
Jun 08
2022
|
Shamim Ruff Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,105
+45.17%
|
$173,570
$34.76 P/Share
|
|
Jan 03
2022
|
Martin Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+50.0%
|
$1,593
$27.32 P/Share
|
|
Jan 03
2022
|
William D. Mc Clellan Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+50.0%
|
$1,593
$27.32 P/Share
|
|
Jan 03
2022
|
Shamim Ruff Director |
BUY
Grant, award, or other acquisition
|
Direct |
118
+50.0%
|
$3,186
$27.32 P/Share
|
|
Jan 03
2022
|
Michael D Wortley Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+50.0%
|
-
|
|
Jan 03
2022
|
Manmeet Singh Soni COO, CFO and President |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+42.02%
|
-
|
|
Jan 03
2022
|
Colin John Meyer Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+40.23%
|
-
|
|
Jan 03
2022
|
Dawn Carter Bir Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+50.0%
|
-
|
|
Jan 03
2022
|
Bhaskar Anand SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+43.1%
|
-
|
|
Dec 31
2021
|
Manmeet Singh Soni COO, CFO and President |
BUY
Open market or private purchase
|
Direct |
16,000
+45.71%
|
$416,000
$26.22 P/Share
|
|
Jun 15
2021
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
40,000
-13.45%
|
$5,680,000
$142.52 P/Share
|
|
Jun 14
2021
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
20,000
-7.06%
|
$2,880,000
$144.9 P/Share
|
|
Jun 14
2021
|
Colin John Meyer Chief Innovation Officer |
BUY
Conversion of derivative security
|
Direct |
5,000
+6.1%
|
-
|
|
Jun 09
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,454
-19.01%
|
$1,200,468
$142.18 P/Share
|
|
Jun 09
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
BUY
Conversion of derivative security
|
Direct |
8,454
+26.88%
|
-
|
|
Jun 07
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,546
-4.92%
|
$225,716
$146.82 P/Share
|
|
Jun 07
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
BUY
Conversion of derivative security
|
Direct |
1,546
+8.77%
|
-
|
|
May 26
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,000
-40.74%
|
$1,240,000
$124.55 P/Share
|
|
May 26
2021
|
Elaine Castellanos VP, Chief Accounting Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+28.95%
|
-
|
|
Dec 23
2020
|
R Kent Mc Gaughy Jr |
SELL
Other acquisition or disposition
|
Indirect |
166,666
-5.44%
|
-
|
|
Dec 23
2020
|
Cpmg Inc |
SELL
Other acquisition or disposition
|
Indirect |
166,666
-100.0%
|
-
|
|
Nov 18
2020
|
Elaine Castellanos VP, Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
600
-3.96%
|
-
|
|
Nov 17
2020
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
6,395
-2.1%
|
$1,061,570
$166.61 P/Share
|
|
Nov 17
2020
|
Colin John Meyer Chief Innovation Officer |
BUY
Conversion of derivative security
|
Direct |
6,395
+7.54%
|
-
|
|
Nov 16
2020
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
18,605
-3.64%
|
$3,218,665
$173.03 P/Share
|
|
Nov 16
2020
|
Colin John Meyer Chief Innovation Officer |
BUY
Conversion of derivative security
|
Direct |
18,605
+17.04%
|
-
|
|
Nov 12
2020
|
Elaine Castellanos VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,500
-18.77%
|
$616,000
$176.02 P/Share
|
|
Nov 12
2020
|
Elaine Castellanos VP, Chief Accounting Officer |
BUY
Conversion of derivative security
|
Direct |
3,500
+15.8%
|
-
|
|
Nov 12
2020
|
William D. Mc Clellan Jr. Director |
SELL
Open market or private sale
|
Direct |
4,000
-76.69%
|
$692,000
$173.49 P/Share
|
|
Nov 12
2020
|
William D. Mc Clellan Jr. Director |
BUY
Conversion of derivative security
|
Direct |
4,000
+50.0%
|
-
|
|
Nov 11
2020
|
Michael D Wortley Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
51,429
-50.95%
|
$9,257,220
$180.02 P/Share
|
|
Nov 11
2020
|
Michael D Wortley Chief Legal Officer |
BUY
Conversion of derivative security
|
Direct |
51,429
+50.0%
|
-
|
|
Nov 10
2020
|
James Warren Huff Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
64,970
-100.0%
|
$11,369,750
$175.0 P/Share
|
|
Nov 09
2020
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
60,000
-75.0%
|
$9,720,000
$162.5 P/Share
|
|
Nov 09
2020
|
Dawn Carter Bir Chief Commercial Officer |
BUY
Conversion of derivative security
|
Direct |
60,000
+50.0%
|
-
|
|
Nov 09
2020
|
James Warren Huff Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,687
-20.44%
|
$2,920,225
$175.06 P/Share
|